Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection
Clinical trial NCT01887912 · TERMINATED
Trial details
- NCT number
- NCT01887912
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-30
- Primary completion
- 2018-06-12
- Enrollment
- 9302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.